We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novo Nordisk Seeks To Halt Sanofi Insulin Pen

Law360 (September 12, 2007, 12:00 AM EDT) -- Novo Nordisk A/S is asking a New Jersey federal court to stop Sanofi-Aventis sales of recently launched insulin pen SoloStar.

Novo Nordisk filed a motion for a preliminary injunction on Monday...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.